Open call for tenders
Open-House-Vergabe 2024-4
Pharmaceutical products · for AOK Bremen/Bremerhaven · Germany · published in German
What the buyer wants
Open-House-Verträge für diverse Wirkstoffe bis 31.12.2025 bzw. 30.11.2026.
2 lots
- Wirkstoff: Bosutinib ATC-Code: L01EA04
- Wirkstoff: Tocilizumab ATC-Code: L04AC07
Companies that won similar tenders
Companies that won public tenders in the same category (Pharmaceutical products) since 2024, according to EU award notices. Likely competitors, or partners for a joint offer.
- Substipharm · France4 wins · last 13 Aug 2025
- Myhrabc · Czechia543 wins · last 4 Nov 2026
- pharmos.cz · Czechia398 wins · last 5 Nov 2026
- Novartis · Czechia10 wins · last 2 Nov 2026
- Janssen-Cilag · United Kingdom6 wins · last 16 May 2025
- lekarnalemon.cz · Czechia4 wins · last 4 Nov 2026
- Panpharma · France4 wins · last 16 May 2025
- Grindeks Kalceks Suomi · Finland3 wins · last 8 Sep 2026
- Provepharm · France3 wins · last 16 May 2025
- Lso Medical · France2 wins · last 13 Mar 2025
- Aspironix · Czechia1 win · last 28 May 2026
- lekarna.cz · Czechia1 win · last 29 Sep 2025
and 4 more.